Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines

International Journal of Oncology

Volumn 29, Issue 6, 2006, Pages 1429-1435

  Savage, Kay ^a   Waller, H Anne ^a   Stubbs, Mark ^a   Khan, Korsa ^a   Watson, Susan A ^b   Clarke, Philip A ^b   Grimes, Steve ^c   Michaeli, Dov ^c   Dhillon, Amar P ^a   Caplin, Martyn E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Aphton Corporation   (United States)

Author keywords

Cancer; CCK BR; Gastrin; Immunocytochemistry; Immunotherapy

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; MESSENGER RNA;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; COLON TUMOR; CONFOCAL MICROSCOPY; ENDOCYTOSIS; GENETICS; HUMAN; IMMUNOBLOTTING; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METHODOLOGY; MOUSE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; RAT; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENDOCYTOSIS; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; MICE; MICROSCOPY, CONFOCAL; NIH 3T3 CELLS; PANCREATIC NEOPLASMS; RATS; RECEPTOR, CHOLECYSTOKININ B; RNA, MESSENGER;

EID: 39049181752     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.6.1429     Document Type: Article

References (59)

1. Edkins JS: The chemical mechanism of gastric secretion. J Physiol 34: 133-144, 1906.
2. Waldum HL, Brenna E, Kleveland PM and Sandvik AK: Gastrin - physiological and pathophysiological consequences. Dig Dis 13: 25-38, 1995.
3. Ekundayo AA, Lee CY and Goodlad RA: Gastrin and the growth of the gastrointestinal tract. Gut 2: 203-208, 1995.
4. Townsend CM, Beauchamp RD, Singh P and Thompson JC: Growth factors and intestinal neoplasms. Am J Surg 155: 526-536, 1988.
5. Smith AM and Watson SA: Gastrin and colorectal cancer. Aliment Pharmacol Ther 14: 1231-1247, 2000.
6. Watson S, Durrant L and Morris D: Gastrin growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer 59: 554-558, 1989. (Pubitemid 19111745)
7. Singh P, Walker JP, Townsend CM and Thompson JC: Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALBc mice. Cancer Res 46: 1612-1616, 1987.
8. Rehfeld IF, Bardram L and Histed L: Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res 49: 2840-2843, 1989.
9. Blackmore M, Doherty E, Manning IF and Hirst BH: Autocrine growth stimulation of human Wilms tumour G401 cells by a gastrin-like peptide. Int J Cancer 57: 385-391, 1994. (Pubitemid 24168614)
10. Dockray GJ, Varro A and Dimaline R: Gastric endocrine cells: gene expression, processing and targeting of active products. Physiol Rev 76: 767-798, 1996. (Pubitemid 26286078)
11. Kopin AS, Lee YM, McBride EW, et al: Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89: 3605-3609, 1992.
12. Sankaran H, Goldfine ID, Deveney CW, Wong KY and Williams JA: Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem 255: 1849-1853, 1980.
13. Innis RB and Snyder SH: Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 77: 6917-6921, 1980.
14. Pisegna JR, de Weerth A, Huppi K and Wank SA: Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 30: 96-303, 1992.
15. Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LF Jr and Kopin AS: The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 268: 8164-8169, 1993.
16. Wank SA, Pisegna JR and de Weerth A: Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89: 8691-8695, 1992.
17. Baldwin GS and Shulkes A: Gastrin, gastrin receptors and colorectal carcinoma. Gut 42: 581-584, 1998.
18. Watson SA, Clarke PA, Smith AM, et al: Expression of CCK-B/gastrin receptor isoforms in gastro-intestinal tumours. Int J Cancer 77: 572-577, 1998. (Pubitemid 28340906)
19. McWilliams DF, Watson SA, Crosbee DM, Michaeli D and Seth R: Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut 42: 795-798, 1998. (Pubitemid 28277219)
20. Okada N, Kubota A, Imamura T, et al: Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer. Cancer Lett 106: 257-262, 1996. (Pubitemid 26325477)
21. Frucht H, Gazdar AF, Park JA, Oie H and Jensen RT: Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52: 1114-1122, 1992.
22. Caplin ME, Millson C, Michaeli D, Watson SA and Dhillon AP: Serum gastrin levels and identification of CCK-B/gastrin receptor following partial hepatectomy for liver tumours in man. Gastroenterology 110: A1162, 1996.
23. Matsumori Y, Katakami N, Ito M, et al: Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer. Cancer Res 55: 276-279, 1995.
24. Lignon MF, Bernad N and Martinez J: Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line. Mol Pharmacol 39: 615-620, 1991.
25. Iwata N, Murayama T, Matsumori Y, et al: Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells. Blood 88: 2683-2689, 1996.
26. Hur K, Kwak MK, Lee HJ, Park do J, Lee HK, Lee HS, Kim WH, Michaeli D and Yang HK: Expression of gastrin and its receptor in human gastric cancer tissues. J Cancer Res Clin Oncol 132: 85-91, 2006.
27. Caplin M, Khan K, Savage K, et al: Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J Hepatol 30: 519-526, 1999. (Pubitemid 29113244)
28. Caplin M, Savage K, Khan K, et al: Expression and processing of gastrin in pancreatic adenocarcinoma. Br J Surg 87: 1035-1040, 2000. (Pubitemid 30496852)
29. Caplin ME, Clarke P, Grimes S, et al: Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. Regul Pept 84: 81-89, 1999.
30. Tarasova NI, Wank SA, Hudson EA, et al: Endocytosis of gastrin in cancer cells expressing gastrin/CCK-B receptor. Cell Tissue Res 287: 325-333, 1997.
31. Seva C, De Vries L, Scemama JL, et al: Gastrin modulates growth of a rat acinar pancreatic cell line: receptor analysis and signal transduction. Digestion 46: 166-169, 1990. (Pubitemid 20298711)
32. Schwartz AL, Fridovich SE, Knowles BB and Lodish HF: Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem 256: 8878-8881, 1981.
33. Watson SA, Morris TM, Crosbee DM and Hardcastle JD: A hepatic invasive human colorectal xenograft model. Eur J Cancer 29A: 1740-1745, 1993.
34. Ito M, Iwata N, Taniguchi T, Murayama T, Chihara K and Matsui T: Functional characterisation of two cholecystokinin-B/gastrin receptor isoforms: a preferential splice donor site in the human receptor gene. Cell Growth Differ 5: 1127-1135, 1994. (Pubitemid 24312288)
35. Czerwinski G, Wank SA, Tarasova NI, Hudson EA, Resau JH and Michejda CJ: Synthesis and properties of three fluorescent derivatives of gastrin. Lett Pept Sci 1: 235-242, 1995.
36. Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J, et al: Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem 47: 1179-1188, 1999.
37. Harlow E and Lane D: Labelling antibodies. In: Antibodies: A Laboratory Manual. Cold Spring Harbour Laboratories, New York, pp319-358, 1988.
38. Smith AM, Watson SA, Caplin M, et al: Gastric carcinoid expresses the gastrin autocrine pathway. Br J Surg 85: 1285-1289, 1998. (Pubitemid 28430438)
39. Seva C, Dickinson CJ and Yamada T: Growth promoting effects of glycine-extended progastrin. Science 265: 410-412, 1994. (Pubitemid 24259977)
40. Baldwin GS: Gastrin receptor structure. In: Gastrin. Walsh JH (ed). Raven, New York, pp195-203, 1993.
41. Narayan S, Chicone L and Singh P: Characterisation of gastrin binding to colonic mucosal membranes of guinea pigs. Mol Cell Biochem 112: 163-171, 1992.
42. Le Meuth V, Philouze-Rome V, Hueron-Luron IL, et al: Differential expression of A- and B- subtypes of cholecystokinin/ gastrin receptors in the developing calf pancreas. Endocrinology 133: 1182-1191, 1993. (Pubitemid 23267770)
43. Miyake A: A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon. Biochem Biophys Res Commun 208: 230-237, 1995.
44. Podlecki DA, Smith RM, Kao M, et al: Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects. J Biol Chem 262: 3362-3368, 1987. (Pubitemid 17127550)
45. Curtis BM, Widmer MB, deRoos P and Qwarnstrom EE: IL-1 and its receptor are translocated to the nucleus. J Immunol 144: 1295-1303, 1990.
46. Holt SJ, Alexander P, Inman CB and Davies DE: Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus. Biochem Pharmacol 47: 117-126, 1994. (Pubitemid 24045823)
47. Rakowicz-Szulczynska E, Otwiaska D, Rodeck U and Koprowski H: Epidermal growth factor (EGF) and monoclonal antibody to cell surface EGF receptor bind to the same chromatin receptor. Arch Biochem Biophys 268: 456-464, 1989.
48. Rakowicz-Szulczynska EM, Rodeck U, Herlyn M and Koprowski H: Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. Proc Natl Acad Sci USA 83: 3728-3732, 1986.
49. Watson SA, Clarke PA, Morris TM and Caplin ME: Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumour. Cancer Res 60: 5902-5907, 2000.
50. Krenning EP, Kwekkeboom DJ, Valkema R, Pauwels S, Kvols LK and De Jong M: Peptide receptor radionuclide therapy. Ann NY Acad Sci 1014: 234-245, 2004.
51. Reubi JC, Macke HR and Krenning EP: Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med 46 (suppl 1): 67S-75S, 2005.
52. 1]-Octreotide in patients with neuroendocrine tumors. J Nucl Med 41: 1514-1518, 2000.
53. Behr TM, Behe M, Angerstein C, et al: Choecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin Cancer Res 5 (suppl 10): 3124s-3138s, 1999.
54. Behr TM, Jenner N, Behe M, et al: Radiolabelled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumours. J Nucl Med 40: 1029-1044, 1999.
55. Behe M, Becker W, Gotthardt M, Angerstein C and Behr TM: Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives. Eur J Nucl Med Mol Imaging 30: 1140-1146, 2003.
56. Gotthardt M, Behe MP, Alfke H and Behr TM: Imaging lung tumors with peptide-based radioligands. Clin Lung Cancer 5: 119-124, 2003.
57. Nock BA, Maina T, Behe M, et al: CCK-2/gastrin receptor-targeted tumor imaging with (99m) Tc-labeled minigastrin analogs. J Nucl Med 46: 1727-1736, 2005.
58. Stubbs M, Khan K, Wickremasinghe RG, Ganeshaguru K and Caplin ME: CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. Oncol Rep 14: 1055-1058, 2005.
59. Gunther R, Carstens OC, Schmidt WE and Folsch UR: Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells. Pancreatology 3: 47-54, 2003.